Literature DB >> 7523569

Activation of human dendritic cells through CD40 cross-linking.

C Caux1, C Massacrier, B Vanbervliet, B Dubois, C Van Kooten, I Durand, J Banchereau.   

Abstract

Dendritic cells, the professional antigen-presenting cells (APC) involved in T cell priming, express CD40, a molecule which triggering plays a key role in B cell growth and differentiation as well as monocyte activation. Herein we demonstrate that dendritic Langerhans cells (D-Lc) generated by culturing cord blood CD34+ progenitor cells with granulocyte/macrophage colony-stimulating and tumor necrosis factor alpha (TNF-alpha) express functional CD40 at a density higher than that found on B cells. Culturing D-Lc on CD40-ligand (CD40L) transfected L cells allowed D-Lc survival as 50 +/- 15% of seeded cells were recovered after 4 d while only 5% survived over control L cells. CD40 activation induced important morphological changes with a reduction of cytoplasmic content and a remarkable increase of dendrite development as well as an altered phenotype. In particular, CD40 triggering induced maintenance of high levels of major histocompatibility complex class II antigens and upregulation of accessory molecules such as CD58, CD80 (B7-1) and CD86 (B7-2). CD40 engagement also seems to turn on D-Lc maturation as illustrated by upregulation of CD25, a molecule usually expressed on interdigitating dendritic cells of secondary lymphoid organs. Finally, CD40 activated D-Lc secreted a limited set of cytokines (TNF-alpha, IL-8, and macrophage inflammatory protein 1 alpha [MIP-1 alpha]) whereas a similar activation induced elutriated monocytes to secrete IL-1 alpha, IL-1 beta, IL-6, IL-8, IL-10, TNF-alpha, and MIP-1 alpha. As D-Lc activated T cells upregulated CD40L, it is likely that CD40 activation of D-Lc observed herein with a fibroblast cell line stably expressing CD40L, mimics physiological interactions between dendritic cells and T cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7523569      PMCID: PMC2191669          DOI: 10.1084/jem.180.4.1263

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

Review 1.  The biology of the human ligand for CD40.

Authors:  M K Spriggs; W C Fanslow; R J Armitage; J Belmont
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

2.  Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T cells.

Authors:  D Macchia; F Almerigogna; P Parronchi; A Ravina; E Maggi; S Romagnani
Journal:  Nature       Date:  1993-06-03       Impact factor: 49.962

3.  Immune functions of tumor necrosis factor. I. Tumor necrosis factor induces apoptosis of mouse thymocytes and can also stimulate or inhibit IL-6-induced proliferation depending on the concentration of mitogenic costimulation.

Authors:  T Hernández-Caselles; O Stutman
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

4.  Induction of human IgE synthesis in B cells by mast cells and basophils.

Authors:  J F Gauchat; S Henchoz; G Mazzei; J P Aubry; T Brunner; H Blasey; P Life; D Talabot; L Flores-Romo; J Thompson
Journal:  Nature       Date:  1993-09-23       Impact factor: 49.962

5.  Dendritic cells freshly isolated from human blood express CD4 and mature into typical immunostimulatory dendritic cells after culture in monocyte-conditioned medium.

Authors:  U O'Doherty; R M Steinman; M Peng; P U Cameron; S Gezelter; I Kopeloff; W J Swiggard; M Pope; N Bhardwaj
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

6.  CD40 expression by human monocytes: regulation by cytokines and activation of monocytes by the ligand for CD40.

Authors:  M R Alderson; R J Armitage; T W Tough; L Strockbine; W C Fanslow; M K Spriggs
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

7.  Human interleukin 10 induces naive surface immunoglobulin D+ (sIgD+) B cells to secrete IgG1 and IgG3.

Authors:  F Brière; C Servet-Delprat; J M Bridon; J M Saint-Remy; J Banchereau
Journal:  J Exp Med       Date:  1994-02-01       Impact factor: 14.307

8.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions.

Authors:  A J Van den Eertwegh; R J Noelle; M Roy; D M Shepherd; A Aruffo; J A Ledbetter; W J Boersma; E Claassen
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

9.  The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4+ T cell clones provides a costimulatory signal for human B cell activation.

Authors:  G Aversa; J Punnonen; J E de Vries
Journal:  J Exp Med       Date:  1993-06-01       Impact factor: 14.307

10.  In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39.

Authors:  T M Foy; D M Shepherd; F H Durie; A Aruffo; J A Ledbetter; R J Noelle
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  286 in total

1.  Interleukin-10 does not affect phagocytosis of particulate antigen by bone marrow-derived dendritic cells but does impair antigen presentation.

Authors:  L Faulkner; G Buchan; M Baird
Journal:  Immunology       Date:  2000-04       Impact factor: 7.397

Review 2.  Adult pulmonary Langerhans' cell histiocytosis.

Authors:  A Tazi; P Soler; A J Hance
Journal:  Thorax       Date:  2000-05       Impact factor: 9.139

Review 3.  Chemokines and dendritic cell traffic.

Authors:  S Sozzani; P Allavena; A Vecchi; A Mantovani
Journal:  J Clin Immunol       Date:  2000-05       Impact factor: 8.317

4.  CD40 signaling in human dendritic cells is initiated within membrane rafts.

Authors:  P O Vidalain; O Azocar; C Servet-Delprat; C Rabourdin-Combe; D Gerlier; S Manié
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

5.  Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.

Authors:  Laurence M Howard; Serge Ostrovidov; Cassandra E Smith; Mauro C Dal Canto; Stephen D Miller
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

6.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 7.  The CD40/CD40L costimulatory pathway in inflammatory bowel disease.

Authors:  S Danese; M Sans; C Fiocchi
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  Associations between autoimmune thyroid disease prognosis and functional polymorphisms of susceptibility genes, CTLA4, PTPN22, CD40, FCRL3, and ZFAT, previously revealed in genome-wide association studies.

Authors:  Naoya Inoue; Mikio Watanabe; Hiroya Yamada; Kazuya Takemura; Fumiaki Hayashi; Noriko Yamakawa; Maiko Akahane; Yu Shimizuishi; Yoh Hidaka; Yoshinori Iwatani
Journal:  J Clin Immunol       Date:  2012-06-17       Impact factor: 8.317

9.  Increased expression of Toll-like receptor (TLR) 2 and TLR4 in the colonic mucosa of children with inflammatory bowel disease.

Authors:  B Szebeni; G Veres; A Dezsõfi; K Rusai; A Vannay; M Mraz; E Majorova; A Arató
Journal:  Clin Exp Immunol       Date:  2007-11-07       Impact factor: 4.330

10.  Immune regulatory loops determine productive interactions within human T lymphocyte-dendritic cell clusters.

Authors:  G Stuhler; A Zobywalski; F Grünebach; P Brossart; V L Reichardt; H Barth; S Stevanovic; W Brugger; L Kanz; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.